Feb 21 Medtronic Plc, the world's
largest standalone medical device maker, reported a 5 percent
rise in quarterly revenue on Tuesday, driven by higher demand
for its heart, vascular and minimally invasive products.
Net income attributable to Medtronic fell to $821 million,
or 59 cents per share, in the third quarter ended Jan. 27 from
$1.10 billion, or 77 cents per share, a year earlier.
The company's net sales rose to $7.28 billion from $6.93
Medtronic, which redomiciled to Ireland through the Covidien
deal, relies on its core business of developing and selling
heart devices, spinal implants, insulin pumps among others.
(Reporting by Akankshita Mukhopadhyay in Bengaluru; Editing by